Menu
← Oncology Approval Tracker
FDA DECISION ·
Onivyde + oxaliplatin + fluorouracil + leucovorin
irinotecan liposome with oxaliplatin, fluorouracil and leucovorin · Ipsen Biopharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First-line treatment of metastatic pancreatic adenocarcinoma with liposomal irinotecan, oxaliplatin, fluorouracil and leucovorin.
LAMPGEN ANALYSIS
Why it matters
The NALIRIFOX regimen added a first-line liposomal irinotecan-based option supported by a head-to-head trial.
What research teams should watch
Clearly identify the liposomal product in orders and coordinate diarrhea plans, laboratory review and infusion pump handoffs.
PRIMARY RECORDS